News and Trends 17 Mar 2023
Purple Biotech sees positive results from cancer study
Purple Biotech Ltd. has released new results from exploratory analyses conducted as part of a phase 1 dose escalation study that assessed the safety and tolerability of nivolumab and CM24,…